Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 400Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Perspectives in Clinical Research

Submit your manuscripts

  • Online submission
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review

Submit article online



April-June 2021 | Vol 12 | Issue  2 Table ofContents RSS Feed
Medication package inserts: Complete, accurate, and up-to-date
Veena Jaguste
While technical definition of package insert (PI) of a medication/device is – “printed leaflets accompanying marketed drug products and contain information approved by regulatory authoriti...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Review Article
The changing perspective of clinical trial designs
Yamini Ajmera, Sunny Singhal, SN Dwivedi, AB Dey
Maintaining health and well-being of the population is a universal priority. Governments around the globe are therefore seeking greater efficiency and better outcomes from researches being held. Altho...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Has mandatory prospective registration of all studies brought about a change? A 1-year audit of studies registered in the Clinical Trials Registry of India [CTRI] before and after April 1, 2018
Nayana S Shetty, Rachana A Salvi, Urmila M Thatte, Nithya J Gogtay
Introduction: The Clinical Trials Registry of India (CTRI) that initially permitted retrospective registration moved to mandatory prospective registration of studies with effect from April 1, 2...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
Original Article
Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients
Bhavya H Vyas, Nishita H Darji, Devang A Rana, Kaushal Y Vyas, Supriya D Malhotra
Context: The Indian government is dispensing newer direct-acting antiviral (DAA) drugs, which may have impact on hepatitis C virus (HCV) patients’ quality of life (QoL). Aims: To ...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Read more articles....